Riad Agbaria

2.8k total citations
51 papers, 2.3k citations indexed

About

Riad Agbaria is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Riad Agbaria has authored 51 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Epidemiology and 10 papers in Infectious Diseases. Recurrent topics in Riad Agbaria's work include Herpesvirus Infections and Treatments (10 papers), Cytomegalovirus and herpesvirus research (10 papers) and Virus-based gene therapy research (9 papers). Riad Agbaria is often cited by papers focused on Herpesvirus Infections and Treatments (10 papers), Cytomegalovirus and herpesvirus research (10 papers) and Virus-based gene therapy research (9 papers). Riad Agbaria collaborates with scholars based in Israel, United States and Canada. Riad Agbaria's co-authors include Arik Dahan, Smadar Cohen, Avital Beig, Víctor E. Márquez, José C. Merchuk, Mona Dvir‐Ginzberg, Hiroaki Mitsuya, Wei Gao, John S. Driscoll and Tsipi Ben-Kasus and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of the American Chemical Society.

In The Last Decade

Riad Agbaria

51 papers receiving 2.2k citations

Peers

Countries citing papers authored by Riad Agbaria

Since Specialization

Citations

This map shows the geographic impact of Riad Agbaria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riad Agbaria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riad Agbaria more than expected).

Fields of papers citing papers by Riad Agbaria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riad Agbaria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riad Agbaria. The network helps show where Riad Agbaria may publish in the future.

Co-authorship network of co-authors of Riad Agbaria

This figure shows the co-authorship network connecting the top 25 collaborators of Riad Agbaria. A scholar is included among the top collaborators of Riad Agbaria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riad Agbaria. Riad Agbaria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vancomycin Drug Reaction with Eosinophilia and Systemic Symptoms: Meta-Analysis and Pharmacovigilance Study 2025 ·Journal of Clinical Medicine ·(unknown), Yaser Adi, Mahmoud Abu‐Shakra, (unknown), Riad Agbaria	1
2	The role of various transporters in the placental uptake of ofloxacin in an in vitro model of human villous trophoblasts 2018 ·Drug Design Development and Therapy ·Hana Polachek, Nir Debotton, Valeria Feinshtein, (unknown), Zvi Ben‐Zvi, Gershon Holcberg, Riad Agbaria, Arik Dahan	4
3	Medical ethics in Israel—bridging religious and secular values 2017 ·The Lancet ·Alan Jotkowitz, Riad Agbaria, Shimon Glick	9
4	Hydrotropic Solubilization of Lipophilic Drugs for Oral Delivery: The Effects of Urea and Nicotinamide on Carbamazepine Solubility–Permeability Interplay 2016 ·Frontiers in Pharmacology ·Avital Beig, David Lindley, Jonathan M. Miller, Riad Agbaria, Arik Dahan	50
5	The use of captisol (SBE7-β-CD) in oral solubility-enabling formulations: Comparison to HPβCD and the solubility–permeability interplay 2015 ·European Journal of Pharmaceutical Sciences ·Avital Beig, Riad Agbaria, Arik Dahan	54
6	Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development 2014 ·Drug Design Development and Therapy ·Arik Dahan, Omri Wolk, Riad Agbaria	43
7	Oral Delivery of Lipophilic Drugs: The Tradeoff between Solubility Increase and Permeability Decrease When Using Cyclodextrin-Based Formulations 2013 ·PLoS ONE ·Avital Beig, Riad Agbaria, Arik Dahan	118
8	The Twofold Advantage of the Amorphous Form as an Oral Drug Delivery Practice for Lipophilic Compounds: Increased Apparent Solubility and Drug Flux Through the Intestinal Membrane 2012 ·The AAPS Journal ·Arik Dahan, Avital Beig, (unknown), Riad Agbaria, Jonathan M. Miller	70
9	Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach 2012 ·Expert Opinion on Drug Delivery ·Arik Dahan, Mustafa Khamis, Riad Agbaria, Rafik Karaman	57
10	Inhibition of TNFα-induced iNOS expression in HSV-tk transduced 9L glioblastoma cell lines by Marasmius oreades substances through NF-κB- and MAPK-dependent mechanisms 2010 ·Molecular Biology Reports ·(unknown), (unknown), Riad Agbaria, (unknown), Solomon P. Wasser, Abraham Z. Reznick, Jamal Mahajna	20
11	The involvement of nuclear factor-kappa B in cyclooxygenase-2 overexpression in murine colon cancer cells transduced with herpes simplex virus thymidine kinase gene 2006 ·Cancer Gene Therapy ·Alexander Konson, Jamal Mahajna, Abraham Danon, Gilad Rimon, Riad Agbaria	15
12	The history of N-methanocarbathymidine: The investigation of a conformational concept leads to the discovery of a potent and selective nucleoside antiviral agent 2006 ·Antiviral Research ·Víctor E. Márquez, Stephen H. Hughes, Shizuko Sei, Riad Agbaria	55
13	Entrapment of retroviral vector producer cells in three‐dimensional alginate scaffolds for potential use in cancer gene therapy 2006 ·Journal of Biomedical Materials Research Part B Applied Biomaterials ·Mona Dvir‐Ginzberg, Alexander Konson, Smadar Cohen, Riad Agbaria	13
14	Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells 2005 ·Biochemical Pharmacology ·Tsipi Ben-Kasus, Zvi Ben‐Zvi, Víctor E. Márquez, James A. Kelley, Riad Agbaria	73
15	Lycopene in serum, skin and adipose tissues after tomato-oleoresin supplementation in patients undergoing haemorrhoidectomy or peri-anal fistulotomy 2003 ·British Journal Of Nutrition ·(unknown), Shlomo Walfisch, Riad Agbaria, Joseph Levy, Yoav Sharoni	43
16	Pharmacokinetics and organ distribution of N -methanocarbathymidine, a novel thymidine analog, in mice bearing tumors transduced with the herpes simplex thymidine kinase gene 2002 ·Cancer Chemotherapy and Pharmacology ·Roy Noy, Zvi Ben‐Zvi, (unknown), Fabio Candotti, Harry Ford, John C. Morris, Víctor E. Márquez, David G. Johns, Riad Agbaria	8
17	Biosynthetic Ganciclovir Triphosphate: Its Isolation and Characterization from Ganciclovir-Treated Herpes Simplex Thymidine Kinase-Transduced Murine Cells 2001 ·Biochemical and Biophysical Research Communications ·Riad Agbaria, Fabio Candotti, James A. Kelley, Hao Zhang, David G. Johns, David A. Cooney, R. Michael Blaese, Harry Ford	8
18	Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric gene for metabolic suicide gene transfer 2000 ·Cancer Gene Therapy ·Fabio Candotti, Riad Agbaria, Craig A. Mullen, Renaud Touraine, Jan Balzarini, David G. Johns, R. Michael Blaese	13
19	A Randomized Pilot Study of Alternating or Simultaneous Zidovudine and Didanosine Therapy in Patients with Symptomatic Human Immunodeficiency Virus Infection 1994 ·The Journal of Infectious Diseases ·Robert Yarchoan, Jill Lietzau, (unknown), Otis W. Brawley, James M. Pluda, M. Wayne Saville, Kathleen M. Wyvill, Seth M. Steinberg, Riad Agbaria, Hiroaki Mitsuya, S Broder	64
20	Hydrolysis of iodine labelled urodilatin and ANP by recombinant neutral endopeptidase EC. 3.4.24.11 1994 ·British Journal of Pharmacology ·Zaid Abassi, Eliahu Golomb, Riad Agbaria, Peter P. Roller, (unknown), Harry R. Keiser	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact